Last 7 days
0.9%
Last 30 days
-5.8%
Last 90 days
8.6%
Trailing 12 Months
4.6%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-01 | Patil Neena M | sold | -216,375 | 144 | -1,500 | evp & chief legal officer |
2023-08-29 | Carr Patricia | sold | -20,372 | 143 | -142 | svp, chief accounting officer |
2023-08-15 | Patil Neena M | sold | -104,695 | 139 | -750 | evp & chief legal officer |
2023-08-14 | Smith Mark Douglas | sold | -171,454 | 138 | -1,241 | - |
2023-08-14 | Sohn Catherine A. | sold | -171,455 | 138 | -1,241 | - |
2023-08-14 | Winningham Rick E | sold | -171,455 | 138 | -1,241 | - |
2023-08-14 | Cook Jennifer E. | sold | -171,454 | 138 | -1,241 | - |
2023-08-14 | Carr Patricia | sold | -21,828 | 138 | -158 | svp, chief accounting officer |
2023-08-14 | ENRIGHT PATRICK G | sold | -171,455 | 138 | -1,241 | - |
2023-08-14 | McSharry Heather Ann | sold | -185,685 | 138 | -1,344 | - |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-20 | BARCLAYS PLC | added | 35.77 | 1,467,000 | 11,222,000 | 0.01% |
2023-09-12 | Farther Finance Advisors, LLC | added | 11.54 | -210 | 3,595 | -% |
2023-09-07 | ST GERMAIN D J CO INC | new | - | 40,166 | 40,166 | -% |
2023-09-06 | Deep Track Capital, LP | added | 4.17 | -20,633,500 | 154,962,000 | 7.17% |
2023-08-28 | DELPHI MANAGEMENT INC /MA/ | new | - | 1,264,000 | 1,264,000 | 1.31% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | unchanged | - | -2,396,990 | 13,289,600 | 0.13% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -4.93 | -3,040,980 | 12,585,300 | 0.02% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | added | 2.98 | -2,987,000 | 20,418,000 | 0.20% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -10.71 | -435,979 | 1,354,260 | -% |
2023-08-17 | Orion Portfolio Solutions, LLC | reduced | -2.97 | -640,844 | 2,960,780 | 0.03% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Sep 11, 2023 | vanguard group inc | 10.26% | 6,479,474 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.61% | 6,050,625 | SC 13G/A | |
Jan 26, 2023 | blackrock inc. | 10.6% | 6,652,382 | SC 13G/A | |
Jan 20, 2023 | blackrock inc. | 10.6% | 6,652,382 | SC 13G | |
Jan 05, 2023 | jpmorgan chase & co | 4.6% | 2,924,604 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
Jan 28, 2022 | blackrock inc. | 10.5% | 6,450,368 | SC 13G/A | |
Jan 24, 2022 | jpmorgan chase & co | 5.2% | 3,248,156 | SC 13G | |
Feb 11, 2021 | renaissance technologies llc | 5.56% | 3,099,050 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 8.76% | 4,877,893 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 12, 2023 | 8-K | Current Report | |
Sep 11, 2023 | SC 13G/A | Major Ownership Report | |
Sep 06, 2023 | 4 | Insider Trading | |
Sep 01, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 31, 2023 | 4 | Insider Trading | |
Aug 29, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 17, 2023 | 4 | Insider Trading | |
Aug 15, 2023 | 4 | Insider Trading | |
Aug 15, 2023 | 4 | Insider Trading | |
Aug 15, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
LLY | 494.8B | 29.5B | -0.66% | 79.36% | 76.16 | 16.77 | 1.53% | 14.16% |
JNJ | 413.2B | 97.8B | -4.35% | -2.72% | 31.65 | 4.23 | 2.29% | -28.92% |
MRK | 272.8B | 58.3B | -4.37% | 23.96% | 17.88 | 4.63 | 2.00% | -81.24% |
PFE | 182.9B | 77.9B | -10.94% | -25.44% | 8.52 | 2.35 | -23.04% | -26.74% |
BMY | 150.1B | 45.2B | -5.70% | -15.91% | 23.72 | 3.25 | -4.15% | 20.34% |
MID-CAP | ||||||||
RETA | 6.5B | - | 1.99% | 679.20% | -74.1 | 4.1K | -86.94% | 71.24% |
PRGO | 4.3B | 4.6B | -16.08% | -16.44% | -62.89 | 0.92 | 6.60% | 42.04% |
SMALL-CAP | ||||||||
SUPN | 1.6B | 634.0M | -6.94% | -10.23% | 36.56 | 2.5 | 0.62% | -24.59% |
TLRY | 1.6B | 627.1M | -7.75% | -11.11% | -1.08 | 2.51 | -0.20% | -204.67% |
INVA | 858.4M | 244.3M | -1.05% | 13.25% | 4.35 | 3.51 | -39.50% | -4.99% |
CRON | 804.1M | 109.5M | 24.85% | -25.44% | -5.6 | 7.34 | -2.66% | -32.13% |
CGC | 507.6M | 453.3M | 136.46% | -66.34% | -0.41 | 1.12 | -16.04% | 55.90% |
ACRS | 469.2M | 31.2M | -3.91% | -52.16% | -4.46 | 15.05 | 407.54% | -26.47% |
OCUL | 255.1M | 54.6M | -17.22% | -39.02% | -2.81 | 4.67 | 9.39% | -179.16% |
ENDP | - | 2.2B | - | - | - | - | -22.39% | 63.59% |
4.0%
0.8%
-4.4%
-1.6%
78.8%
49.6%
0%
Y-axis is the maximum loss one would have experienced if Jazz Pharmaceuticals was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 0.7% | 3,762,904,000 | 3,738,465,000 | 3,659,374,000 | 3,583,982,000 | 3,481,445,000 | 3,300,378,000 | 3,094,238,000 | 2,863,024,000 | 2,625,797,000 | 2,436,422,000 | 2,363,567,000 | 2,279,790,000 | 2,216,604,000 | 2,188,301,000 | 2,161,761,000 | 2,056,478,000 | 1,988,149,000 | 1,954,495,000 | 1,890,922,000 | 1,850,864,000 | 1,793,346,000 |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1,276,084,000 | 1,279,876,000 | 1,324,681,000 |
S&GA Expenses | -1.8% | 1,380,442,000 | 1,406,071,000 | 1,416,967,000 | 1,432,226,000 | 1,437,430,000 | 1,499,988,000 | 1,451,683,000 | 1,300,393,000 | 1,143,966,000 | 906,341,000 | 854,233,000 | 821,336,000 | 792,787,000 | 777,395,000 | 736,942,000 | 684,532,000 | 661,699,000 | 644,264,000 | 683,530,000 | 664,715,000 | 633,365,000 |
R&D Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 299,726,000 | 259,001,000 | 230,306,000 | 224,054,000 | 226,616,000 | 235,954,000 | 232,156,000 |
EBITDA | 100.0% | - | -23,078,000 | -71,811,000 | -47,336,000 | -54,661,000 | -122,761,000 | 3,762,000 | - | - | 714,883,000 | 369,895,000 | 245,457,000 | 191,526,000 | 204,190,000 | 528,702,000 | 650,892,000 | 705,784,000 | - | - | - | - |
EBITDA Margin | 100.0% | - | -0.01 | -0.02 | -0.01 | -0.02 | -0.04 | 0.00 | - | - | 0.29 | 0.16 | 0.11 | 0.09 | 0.09 | 0.24 | 0.32 | 0.35 | - | - | - | - |
Interest Expenses | - | - | - | 270,671,000 | - | - | - | 138,271,000 | - | - | - | 42,470,000 | - | - | - | 43,002,000 | - | - | - | 42,706,000 | - | - |
Earnings Before Taxes | 18.8% | -263,238,000 | -324,008,000 | -372,784,000 | -77,621,000 | -85,125,000 | -242,199,000 | -112,838,000 | 76,797,000 | 312,571,000 | 620,083,000 | 275,095,000 | 171,057,000 | 117,126,000 | 129,790,000 | 454,302,000 | 578,992,000 | 633,884,000 | 579,199,000 | 529,463,000 | 482,931,000 | 378,868,000 |
EBT Margin | 100.0% | - | -0.09 | -0.10 | -0.02 | -0.02 | -0.07 | -0.04 | 0.03 | 0.12 | 0.25 | 0.12 | 0.08 | 0.05 | 0.06 | 0.21 | - | - | - | - | - | - |
Net Income | 44.6% | -86,514,000 | -156,287,000 | -224,060,000 | -18,687,000 | -51,872,000 | -449,853,000 | -329,668,000 | -160,903,000 | 40,164,000 | 518,281,000 | 238,616,000 | 179,194,000 | 133,236,000 | 280,333,000 | 523,367,000 | 608,845,000 | 655,885,000 | 486,308,000 | 447,098,000 | 519,835,000 | 434,045,000 |
Net Income Margin | 100.0% | - | -0.04 | -0.06 | -0.01 | -0.01 | -0.14 | -0.11 | -0.06 | 0.02 | 0.21 | 0.10 | 0.08 | 0.06 | 0.13 | 0.24 | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 1,363,130,000 | 1,242,931,000 | 1,078,126,000 | 920,965,000 | 664,724,000 | 750,866,000 | 765,234,000 | 754,022,000 | 899,334,000 | 884,644,000 | 783,149,000 | 855,045,000 | 810,100,000 | 736,266,000 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 1.9% | 11,261 | 11,047 | 10,835 | 10,385 | 11,200 | 11,769 | 12,299 | 12,478 | 13,213 | 6,756 | 6,536 | 6,292 | 6,067 | 5,215 | 5,539 | 5,528 | 5,489 | 5,280 | 5,203 | 5,486 | 5,349 |
Current Assets | 8.1% | 3,010 | 2,785 | 2,606 | 2,572 | 2,591 | 2,501 | 2,611 | 2,628 | 2,954 | 3,167 | 2,840 | 2,556 | 2,302 | 1,518 | 1,630 | 1,521 | 1,370 | 1,306 | 1,234 | 1,464 | 1,307 |
Cash Equivalents | 9.8% | 1,282 | 1,168 | 881 | 839 | 711 | 491 | 591 | 672 | 891 | 2,098 | 1,058 | 742 | 786 | 702 | 637 | 795 | 638 | 547 | 310 | 499 | 485 |
Inventory | -2.6% | 657 | 675 | 714 | 728 | 862 | 985 | 1,073 | 1,138 | 1,251 | 115 | 95.00 | 91.00 | 93.00 | 86.00 | 79.00 | 71.00 | 69.00 | 61.00 | 53.00 | 43.00 | 46.00 |
Net PPE | - | - | - | - | - | - | - | - | - | - | 124 | 128 | 128 | 128 | 130 | 132 | 129 | 127 | 113 | 200 | 198 | 188 |
Goodwill | 1.1% | 1,743 | 1,723 | 1,693 | 1,593 | 1,688 | 1,782 | 1,828 | 1,850 | 1,888 | 938 | 958 | 937 | 918 | 909 | 920 | 907 | 925 | 920 | 928 | 932 | 936 |
Current Liabilities | 4.0% | 945 | 909 | 933 | 813 | 705 | 737 | 809 | 735 | 881 | 752 | 654 | 642 | 410 | 396 | 364 | 390 | 369 | 414 | 345 | 341 | 348 |
LT Debt, Current | 0% | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 249 | 249 | 246 | 244 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 |
LT Debt, Non Current | -0.1% | 5,687 | 5,690 | 5,693 | 5,696 | 5,990 | 5,993 | 6,019 | 6,247 | 6,489 | 1,853 | 1,849 | 1,844 | 2,070 | 1,577 | 1,574 | 1,571 | 1,568 | 1,565 | 1,563 | 1,561 | 1,558 |
Shareholder's Equity | 5.7% | 3,526 | 3,335 | 3,086 | 2,745 | 3,201 | 3,608 | 3,965 | 3,938 | 4,131 | 3,798 | 3,660 | 3,377 | 3,142 | 2,809 | 3,111 | 3,054 | 2,983 | 2,730 | 2,757 | 3,027 | 2,870 |
Retained Earnings | 1.1% | 812 | 803 | 734 | 974 | 994 | 959 | 830 | 866 | 918 | 1,282 | 1,160 | 1,026 | 878 | 771 | 1,068 | 1,104 | 1,022 | 820 | 846 | 1,128 | 1,000 |
Additional Paid-In Capital | 1.9% | 3,580 | 3,512 | 3,477 | 3,388 | 3,312 | 3,239 | 3,535 | 3,470 | 3,403 | 2,695 | 2,634 | 2,538 | 2,499 | 2,294 | 2,266 | 2,209 | 2,171 | 2,131 | 2,114 | 2,078 | 2,037 |
Shares Outstanding | 0.8% | 64.00 | 63.00 | 63.00 | 63.00 | 62.00 | 62.00 | 62.00 | 61.00 | 59.00 | 56.00 | 56.00 | 56.00 | 55.00 | 56.00 | 56.00 | 57.00 | 57.00 | 57.00 | 58.00 | 60.00 | 60.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -0.5% | 1,377 | 1,384 | 1,272 | 1,108 | 964 | 702 | 779 | 787 | 771 | 912 | 900 | 801 | 881 | 847 | 776 | 907 | 791 | 834 | 799 | 785 | 753 |
Share Based Compensation | 3.4% | 236 | 228 | 222 | 214 | 210 | 205 | 189 | 167 | 144 | 127 | 121 | 116 | 114 | 112 | 111 | 111 | 108 | 106 | 102 | 103 | 105 |
Cashflow From Investing | 0.8% | -410 | -413 | -446 | -131 | -163 | -5,986 | -5,212 | -5,128 | -5,381 | -210 | -1,007 | -1,239 | -1,119 | -381 | -155 | 44.00 | 12.00 | -176 | -394 | -466 | -477 |
Cashflow From Financing | -37.2% | -395 | -288 | -529 | -795 | -971 | 3,681 | 3,971 | 4,273 | 4,716 | 694 | 528 | 384 | 388 | -311 | -293 | -652 | -646 | -561 | -479 | -72.66 | -31.66 |
Buy Backs | - | 127 | - | 0.00 | 0.00 | 0.00 | - | - | - | - | 7.00 | 147 | 257 | 277 | 329 | 301 | 638 | 639 | 600 | 524 | 119 | 124 |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenues: | ||||
Total revenues | $ 957,317 | $ 932,878 | $ 1,850,129 | $ 1,746,599 |
Operating expenses: | ||||
Cost of product sales (excluding amortization of acquired developed technologies) | 97,537 | 124,208 | 226,181 | 239,492 |
Selling, general and administrative | 340,844 | 366,473 | 638,761 | 675,286 |
Research and development | 209,238 | 139,047 | 398,648 | 269,028 |
Intangible asset amortization | 152,062 | 148,456 | 301,848 | 320,550 |
Acquired in-process research and development | 0 | 69,148 | 1,000 | 69,148 |
Total operating expenses | 799,681 | 847,332 | 1,566,438 | 1,573,504 |
Income from operations | 157,636 | 85,546 | 283,691 | 173,095 |
Interest expense, net | (73,470) | (63,189) | (147,617) | (133,873) |
Foreign exchange gain (loss) | (2,382) | (1,343) | 811 | (11,883) |
Income before income tax benefit and equity in loss of investees | 81,784 | 21,014 | 136,885 | 27,339 |
Income tax benefit | (24,323) | (16,112) | (39,647) | (15,576) |
Equity in loss of investees | 1,669 | 2,461 | 2,674 | 6,603 |
Net income | $ 104,438 | $ 34,665 | $ 173,858 | $ 36,312 |
Net income per ordinary share: | ||||
Basic (in dollars per share) | $ 1.63 | $ 0.56 | $ 2.73 | $ 0.58 |
Diluted (in dollars per share) | $ 1.52 | $ 0.55 | $ 2.55 | $ 0.57 |
Weighted-average ordinary shares used in per share calculations - basic (in shares) | 63,991 | 62,436 | 63,744 | 62,152 |
Weighted-average ordinary shares used in per share calculations - diluted (in shares) | 73,540 | 63,431 | 73,657 | 63,171 |
Product sales, net | ||||
Revenues: | ||||
Total revenues | $ 946,987 | $ 928,300 | $ 1,831,206 | $ 1,738,137 |
Royalties and contract revenues | ||||
Revenues: | ||||
Total revenues | $ 10,330 | $ 4,578 | $ 18,923 | $ 8,462 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 1,282,304 | $ 881,482 |
Investments | 80,000 | 0 |
Accounts receivable, net of allowances | 610,389 | 651,493 |
Inventories | 657,214 | 714,061 |
Prepaid expenses | 107,490 | 91,912 |
Other current assets | 272,458 | 267,192 |
Total current assets | 3,009,855 | 2,606,140 |
Property, plant and equipment, net | 229,264 | 228,050 |
Operating lease assets | 69,040 | 73,326 |
Intangible assets, net | 5,705,777 | 5,794,437 |
Goodwill | 1,742,675 | 1,692,662 |
Deferred tax assets, net | 430,086 | 376,247 |
Deferred financing costs | 7,865 | 9,254 |
Other non-current assets | 65,978 | 55,139 |
Total assets | 11,260,540 | 10,835,255 |
Current liabilities: | ||
Accounts payable | 98,428 | 90,758 |
Accrued liabilities | 748,304 | 803,255 |
Current portion of long-term debt | 31,000 | 31,000 |
Income taxes payable | 67,529 | 7,717 |
Deferred revenue | 4 | 463 |
Total current liabilities | 945,265 | 933,193 |
Long-term debt, less current portion | 5,686,646 | 5,693,341 |
Operating lease liabilities, less current portion | 65,547 | 71,838 |
Deferred tax liabilities, net | 910,724 | 944,337 |
Other non-current liabilities | 126,683 | 106,812 |
Commitments and contingencies (Note 9) | ||
Shareholders’ equity: | ||
Ordinary shares | 6 | 6 |
Non-voting euro deferred shares | 55 | 55 |
Capital redemption reserve | 473 | 472 |
Additional paid-in capital | 3,580,115 | 3,477,124 |
Accumulated other comprehensive loss | (866,823) | (1,125,509) |
Retained earnings | 811,849 | 733,586 |
Total shareholders’ equity | 3,525,675 | 3,085,734 |
Total liabilities and shareholders’ equity | $ 11,260,540 | $ 10,835,255 |